Johnson & Johnson (JNJ) Holder Confluence Investment Management LLC Has Boosted Holding by $7.03 Million as Shares Declined

August 10, 2018 - By Tina Thibodeau

Johnson & Johnson (NYSE:JNJ) LogoInvestors sentiment increased to 0.93 in Q1 2018. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. 2,156 are owned by Rothschild Cap Ptnrs Ltd Liability Company. Parkwood has 1.35% invested in Johnson & Johnson (NYSE:JNJ) for 73,885 shares. Blume Inc accumulated 59,643 shares. Moreover, Vantage Invest Lc has 2.29% invested in Johnson & Johnson (NYSE:JNJ). Villere St Denis J Ltd has 0.39% invested in Johnson & Johnson (NYSE:JNJ) for 50,774 shares. Butensky & Cohen Finance Security Incorporated holds 15,224 shares. Meritage holds 108,852 shares. Japan-based Sumitomo Mitsui Asset Mngmt has invested 0.48% in Johnson & Johnson (NYSE:JNJ). Df Dent reported 0.35% stake. Stewart Patten Limited Com holds 204,967 shares. Rand Wealth Limited Company owns 118,353 shares for 1.7% of their portfolio. Patten Grp Inc Inc holds 1.36% in Johnson & Johnson (NYSE:JNJ) or 25,905 shares. Old Republic owns 281,800 shares or 1.08% of their US portfolio. Live Your Vision Limited Co holds 0.04% or 861 shares. Wetherby Asset Mgmt accumulated 61,871 shares.

Since February 15, 2018, it had 0 insider purchases, and 1 sale for $20.17 million activity.

Confluence Investment Management Llc increased its stake in Johnson & Johnson (JNJ) by 5.4% based on its latest 2018Q1 regulatory filing with the SEC. Confluence Investment Management Llc bought 54,941 shares as the company’s stock declined 8.03% with the market. The institutional investor held 1.07M shares of the major pharmaceuticals company at the end of 2018Q1, valued at $137.38M, up from 1.02M at the end of the previous reported quarter. Confluence Investment Management Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $351.98 billion market cap company. The stock increased 0.02% or $0.03 during the last trading session, reaching $131.2. About 4.06M shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since August 10, 2017 and is downtrending. It has underperformed by 17.32% the S&P500.

Confluence Investment Management Llc, which manages about $2.30 billion and $5.41B US Long portfolio, decreased its stake in Stryker Corp. (NYSE:SYK) by 26,995 shares to 526,180 shares, valued at $84.67M in 2018Q1, according to the filing. It also reduced its holding in Fastenal Co. (NASDAQ:FAST) by 85,323 shares in the quarter, leaving it with 2.33 million shares, and cut its stake in Nxp Semiconductors N.V. (NASDAQ:NXPI).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: which released: “Sell Microsoft And Don’t Look Back” on August 08, 2018, also with their article: “Johnson & Johnson Looks Too Cheap” published on July 17, 2018, published: “Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings” on July 12, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: and their article: “J&J: Lawsuits And Dividend Safety” published on July 27, 2018 as well as‘s news article titled: “BeiGene launches late-stage study of tislelizumab in first-line lung cancer” with publication date: August 09, 2018.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 10 analysts covering Johnson \u0026 Johnson (NYSE:JNJ), 5 have Buy rating, 0 Sell and 5 Hold. Therefore 50% are positive. Johnson \u0026 Johnson had 15 analyst reports since February 27, 2018 according to SRatingsIntel. Stifel Nicolaus maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, April 18. Stifel Nicolaus has “Hold” rating and $135 target. The firm has “Buy” rating by Credit Suisse given on Thursday, April 12. The firm has “Buy” rating by Jefferies given on Friday, April 13. The rating was maintained by Jefferies on Monday, February 26 with “Buy”. The stock of Johnson & Johnson (NYSE:JNJ) has “Equal-Weight” rating given on Tuesday, April 10 by Morgan Stanley. Deutsche Bank maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, April 18 with “Buy” rating. The firm earned “Buy” rating on Friday, March 23 by Jefferies. As per Wednesday, April 18, the company rating was maintained by Leerink Swann. The stock of Johnson & Johnson (NYSE:JNJ) earned “Outperform” rating by Credit Suisse on Friday, April 20. Credit Suisse maintained Johnson & Johnson (NYSE:JNJ) on Tuesday, June 12 with “Buy” rating.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.